(Q55456747)

11 July 2018

http://europepmc.org/abstract/MED/29943666

title

Recurrent Glioblastoma Treated with Recombinant Poliovirus. (English)

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

1 reference

Poliovirus

1 reference

7

Henry S Friedman

1 reference

11 July 2018

18

Darell D Bigner

1 reference

11 July 2018

1

Annick Desjardins

1 reference

11 July 2018

6

Allan H Friedman

1 reference

11 July 2018

16

Roger E McLendon

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

Frances McSherry

8

Frances McSherry

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

Dina Randazzo

12

Dina Randazzo

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

Dani Bolognesi

5

Dani P Bolognesi

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

James H. Herndon

3

James E Herndon

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

Smita K Nair

10

Smita Nair

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

Matthias Gromeier

2

Matthias Gromeier

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

Katherine B Peters

11

Katherine B Peters

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

author name string

Nike Beaubier

4

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

Andrea M Muscat

9

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

John H Sampson

13

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

Gordana Vlahovic

14

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

William T Harrison

15

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

David Ashley

17

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

language of work or name

English

0 references

publication date

26 June 2018

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

published in

The New England Journal of Medicine

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

volume

379

0 references

issue

2

0 references

page(s)

150-161

0 references

cites work

Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis.

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

A randomized trial of bevacizumab for newly diagnosed glioblastoma

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Cancer immunotherapy comes of age

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76.

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Intergeneric poliovirus recombinants for the treatment of malignant glioma

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily

25 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6065102

25 August 2018

Identifiers

DOI

10.1056/NEJMOA1716435

1 reference

11 July 2018

http://europepmc.org/abstract/MED/29943666

PMC publication ID

6065102

0 references

1 reference

11 July 2018